Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Aged garlic extract
Placebo
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension
Eligibility Criteria
Inclusion Criteria:
- Ability to give written informed consent.
- Age: greater than or equal to 40 and less than or equal to 70 years.
- Systolic blood pressure140-160mmHg and/or diastolic blood pressure 90-100 mmHg
- LDL-C less than or equal to 4.9mmol/L
- Those on a stable dose of blood pressure lowering or lipid-lowering medication for greater than or equal to 3 months; if a participant chooses to stop taking blood pressure lowering medications, they will be required to have a minimum 3 month washout period prior to commencement of the study; all other medications medications will be permitted if they are on a stable dose before the start of the study
- Gender: Male and women who are not pregnant (determined by a negative urine pregnancy test at screening for women of childbearing potential) or lactating.
- Language: Participants must be able to read, write and speak English.
Exclusion Criteria:
- Systolic blood pressure > 160mmHg and/or diastolic blood pressure >100mmHg
- Those currently taking (or have taken within the last 3 months) lipid-lowering or blood pressure-lowering supplements (i.e., omega-3 supplements, plant sterols/stanols foods and/or supplements, fibre, etc.)
- Patients with unstable or serious illness, for example, dementia, terminal illness, recent bereavement, secondary hypertension, recent significant medical diagnosis.
- History of cancer, chronic illness, cardiovascular problems, liver and kidney disease (including chronic kidney disease (GFR < 60ml/min/1.732)), diabetes, inflammatory bowel disease, pancreatitis, gallbladder or biliary disease, neurological/psychological disease, bleeding disorders, experienced platelet abnormalities, macrovascular target organ damage (including cerebrovascular disease, stroke, hypertensive retinopathy, left ventricular dysfunction, angina pectoris, myocardial infarction, and peripheral artery disease)
- History of taking any type of garlic preparation (i.e., dried garlic homogenate, aged garlic extract, processed garlic capsule, time-released garlic powder tablet, regular garlic pill, garlic powder and garlic oil) in the past 6 months. in the past 3 months. (Note: regular garlic clove consumption as part of prepared meals, cooking preparations, etc. are permitted throughout the study period)
- Plan to consume any type of garlic preparation (i.e., dried garlic homogenate, aged garlic extract, processed garlic capsule, time-released garlic powder tablet, regular garlic pill, garlic powder and garlic oil. at any time during the study. (Note: regular garlic clove consumption as part of prepared meals, cooking preparations, etc. are permitted throughout the study period)
- Have gained or lost greater than or equal to 10lbs in the previous 3 months, or plan to lose weight at any time during the study
- Plan to become pregnant during the study period.
- Women of childbearing potential not using effective contraception which include: Hormonal contraceptives including combined oral contraceptives, hormone birth control patch, vaginal contraceptive ring, injectable contraceptives, or hormonal implants; Intrauterine devices (IUD) or Intrauterine system (IUS); Tubal ligation; Vasectomy of partner; Double barrier method (use of physical barrier by both partners, e.g. male condom and diaphragm, male condom and cervical cap)
- Consumption of more than 2 alcoholic drinks/day, or > 14 alcoholic beverages a week, or history of alcoholism or drug dependence.
- History of allergy to garlic, microcrystalline cellulose, silicon dioxide, magnesium stearate, gelatin, hydroxypropylcellulose, or caramel coloring
- Any planned surgeries any time during the study
- Taking medications with psychotropic properties for less than 3 months, i.e., those taking medications with psychotropic properties, such as anti-depressants, anti-anxiety, etc., at a stable consistent dose for a minimum of 3 months are eligible for the study, as long as the medication is consumed at a stable, consistent dose throughout the study period
- Smokers
- Exercising > 15 miles/wk or 4,000 kcal/wk
Sites / Locations
- Richardson Centre for Functional Foods and Nutraceuticals
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Placebo Comparator
Arm Label
Aged garlic extract
Placebo
Arm Description
2 capsules per day containing aged garlic extract
2 capsules per day without aged garlic extract
Outcomes
Primary Outcome Measures
24 hour ambulatory blood pressure
Secondary Outcome Measures
Blood total cholesterol
Blood low-density lipoprotein cholesterol
Blood high-density lipoprotein cholesterol
Blood triglycerides
Office blood pressure
Pulse wave velocity
Measured by Mobil-O-Graph
Augmentation index
Measured by Mobil-O-Graph
Body mass index
Waist circumference
Hip circumference
Full Information
NCT ID
NCT03211767
First Posted
January 3, 2017
Last Updated
February 9, 2019
Sponsor
University of Manitoba
Collaborators
Wakunga of America Co. Ltd., Purity Life Health Products LP
1. Study Identification
Unique Protocol Identification Number
NCT03211767
Brief Title
Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension
Official Title
Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension
Study Type
Interventional
2. Study Status
Record Verification Date
February 2019
Overall Recruitment Status
Completed
Study Start Date
October 12, 2017 (Actual)
Primary Completion Date
July 25, 2018 (Actual)
Study Completion Date
July 25, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Manitoba
Collaborators
Wakunga of America Co. Ltd., Purity Life Health Products LP
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The primary objective of this trial is to assess the effect of consumption of aged garlic extract powder on 24 h systolic and diastolic ambulatory blood pressure in hypertensive individuals following 8 weeks of supplementation.
Additional secondary objectives are to assess the effects of aged garlic extract powder intake for 8 weeks on lipid profile (TC, HDL-C, LDL-C, and TG concentrations), blood glucose, office blood pressure, pulse-wave velocity and augmentation index, body mass index, and waist and hip circumference.
Detailed Description
Forty hypertensive volunteers between 18 and 75 years will be recruited from the Winnipeg (Manitoba, Canada) area to participate in a two arm crossover, double-blind, randomized, placebo-controlled intervention study for 8 weeks per study period following obtainment of informed consent.
The 2 periods of treatment will include:
Treatment period: One capsule twice a day, providing 600 mg each of aged garlic extract powder, for a total of 1200 mg/day of aged garlic extract powder.
Control period: The control product will be an identical-looking placebo capsules containing cellulose, which is being used as a filler in the treatment capsules.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
43 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Aged garlic extract
Arm Type
Active Comparator
Arm Description
2 capsules per day containing aged garlic extract
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
2 capsules per day without aged garlic extract
Intervention Type
Dietary Supplement
Intervention Name(s)
Aged garlic extract
Intervention Description
Each capsule contains 600mg of aged garlic extract powder
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Each capsule contains cellulose as a filler.
Primary Outcome Measure Information:
Title
24 hour ambulatory blood pressure
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Blood total cholesterol
Time Frame
8 weeks
Title
Blood low-density lipoprotein cholesterol
Time Frame
8 weeks
Title
Blood high-density lipoprotein cholesterol
Time Frame
8 weeks
Title
Blood triglycerides
Time Frame
8 weeks
Title
Office blood pressure
Time Frame
8 weeks
Title
Pulse wave velocity
Description
Measured by Mobil-O-Graph
Time Frame
8 weeks
Title
Augmentation index
Description
Measured by Mobil-O-Graph
Time Frame
8 weeks
Title
Body mass index
Time Frame
8 weeks
Title
Waist circumference
Time Frame
8 weeks
Title
Hip circumference
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Ability to give written informed consent.
Age: greater than or equal to 40 and less than or equal to 70 years.
Systolic blood pressure140-160mmHg and/or diastolic blood pressure 90-100 mmHg
LDL-C less than or equal to 4.9mmol/L
Those on a stable dose of blood pressure lowering or lipid-lowering medication for greater than or equal to 3 months; if a participant chooses to stop taking blood pressure lowering medications, they will be required to have a minimum 3 month washout period prior to commencement of the study; all other medications medications will be permitted if they are on a stable dose before the start of the study
Gender: Male and women who are not pregnant (determined by a negative urine pregnancy test at screening for women of childbearing potential) or lactating.
Language: Participants must be able to read, write and speak English.
Exclusion Criteria:
Systolic blood pressure > 160mmHg and/or diastolic blood pressure >100mmHg
Those currently taking (or have taken within the last 3 months) lipid-lowering or blood pressure-lowering supplements (i.e., omega-3 supplements, plant sterols/stanols foods and/or supplements, fibre, etc.)
Patients with unstable or serious illness, for example, dementia, terminal illness, recent bereavement, secondary hypertension, recent significant medical diagnosis.
History of cancer, chronic illness, cardiovascular problems, liver and kidney disease (including chronic kidney disease (GFR < 60ml/min/1.732)), diabetes, inflammatory bowel disease, pancreatitis, gallbladder or biliary disease, neurological/psychological disease, bleeding disorders, experienced platelet abnormalities, macrovascular target organ damage (including cerebrovascular disease, stroke, hypertensive retinopathy, left ventricular dysfunction, angina pectoris, myocardial infarction, and peripheral artery disease)
History of taking any type of garlic preparation (i.e., dried garlic homogenate, aged garlic extract, processed garlic capsule, time-released garlic powder tablet, regular garlic pill, garlic powder and garlic oil) in the past 6 months. in the past 3 months. (Note: regular garlic clove consumption as part of prepared meals, cooking preparations, etc. are permitted throughout the study period)
Plan to consume any type of garlic preparation (i.e., dried garlic homogenate, aged garlic extract, processed garlic capsule, time-released garlic powder tablet, regular garlic pill, garlic powder and garlic oil. at any time during the study. (Note: regular garlic clove consumption as part of prepared meals, cooking preparations, etc. are permitted throughout the study period)
Have gained or lost greater than or equal to 10lbs in the previous 3 months, or plan to lose weight at any time during the study
Plan to become pregnant during the study period.
Women of childbearing potential not using effective contraception which include: Hormonal contraceptives including combined oral contraceptives, hormone birth control patch, vaginal contraceptive ring, injectable contraceptives, or hormonal implants; Intrauterine devices (IUD) or Intrauterine system (IUS); Tubal ligation; Vasectomy of partner; Double barrier method (use of physical barrier by both partners, e.g. male condom and diaphragm, male condom and cervical cap)
Consumption of more than 2 alcoholic drinks/day, or > 14 alcoholic beverages a week, or history of alcoholism or drug dependence.
History of allergy to garlic, microcrystalline cellulose, silicon dioxide, magnesium stearate, gelatin, hydroxypropylcellulose, or caramel coloring
Any planned surgeries any time during the study
Taking medications with psychotropic properties for less than 3 months, i.e., those taking medications with psychotropic properties, such as anti-depressants, anti-anxiety, etc., at a stable consistent dose for a minimum of 3 months are eligible for the study, as long as the medication is consumed at a stable, consistent dose throughout the study period
Smokers
Exercising > 15 miles/wk or 4,000 kcal/wk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Jones, PhD
Organizational Affiliation
University of Manitoba
Official's Role
Principal Investigator
Facility Information:
Facility Name
Richardson Centre for Functional Foods and Nutraceuticals
City
Winnipeg
State/Province
Manitoba
ZIP/Postal Code
R3T 6C5
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Double-Blind, Randomized, Cross-Over Trial of Aged Garlic Extract for Hypertension
We'll reach out to this number within 24 hrs